Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate gpr52 for psychiatric disorders

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Komatsu, Hidetoshi ^a   Maruyama, Minoru ^a   Yao, Shuuhei ^a   Shinohara, Tokuyuki ^a   Sakuma, Kensuke ^a   Imaichi, Sachiko ^a   Chikatsu, Tomoko ^a   Kuniyeda, Kanako ^a   Siu, Foo Kok ^b   Peng, Lam Sock ^b   Zhuo, Katherine ^b   Mun, Lay Sock ^b   Han, Tan Min ^b   Matsumoto, Yoshio ^a   Hashimoto, Tadatoshi ^a   Miyajima, Nobuyuki ^a   Itoh, Yasuaki ^a   Ogi, Kazuhiro ^a   Habata, Yugo ^a   Mori, Masaaki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b TSP CNS Phenotyping Takeda Pharmaceutical Company Limited   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 52; G PROTEIN COUPLED RECEPTOR 6; G PROTEIN COUPLED RECEPTOR 88; RESERPINE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN NERVE CELL; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DRUG RESPONSE; EMBRYO; EMOTION; GLUTAMATERGIC TRANSMISSION; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PSYCHOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; COGNITION; CONSERVED SEQUENCE; CORPUS STRIATUM; DOPAMINERGIC NEURONS; EMOTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RESERPINE; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VENTRAL TEGMENTAL AREA;

EID: 84896500794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090134     Document Type: Article

References (53)

1. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5: 993-996. (Pubitemid 44835126)
2. Gonzalez-Maeso J, Sealfon SC (2009) Agonist-trafficking and hallucinogens. Curr Med Chem 16: 1017-1027.
3. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 294: 1024-1030. (Pubitemid 33041850)
4. Jessell TM, Kandel ER (1993) Synaptic transmission: a bidirectional and selfmodifiable form of cell-cell communication. Cell 72 Suppl: 1-30. (Pubitemid 23051233)
5. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225. (Pubitemid 28070979)
6. Carlsson A (2001) A paradigm shift in brain research. Science 294: 1021-1024. (Pubitemid 33048804)
7. Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43: 261-284. (Pubitemid 37372642)
8. Zhou QY, Palmiter RD (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83: 1197-1209. (Pubitemid 26007810)
9. Jenner P (2003) Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease. Curr Opin Neurol 16 Suppl 1: S3-7. (Pubitemid 38328107)
10. Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251: 238-246.
11. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, et al. (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124: 57-73. (Pubitemid 26112775)
12. Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, et al. (2006) Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20: 389-409. (Pubitemid 43763739)
13. Fredriksson R, Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67: 1414-1425. (Pubitemid 40594140)
14. Regard JB, Sato IT, Coughlin SR (2008) Anatomical profiling of G proteincoupled receptor expression. Cell 135: 561-571.
15. Ikemoto S (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56: 27-78. (Pubitemid 350110353)
16. Ena S, de Kerchove d'Exaerde A, Schiffmann SN (2011) Unraveling the differential functions and regulation of striatal neuron sub-populations in motor control, reward, and motivational processes. Front Behav Neurosci 5: 47.
17. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, et al. (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64: 193-198. (Pubitemid 29052470)
18. Alexander SP, Mathie A, Peters JA (2011) Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 Suppl 1: S1-324.
19. Fagan KA, Schaack J, Zweifach A, Cooper DM (2001) Adenovirus encoded cyclic nucleotide-gated channels: a new methodology for monitoring cAMP in living cells. FEBS Lett 500: 85-90. (Pubitemid 32575324)
20. Hinuma S, Hosoya M, Ogi K, Tanaka H, Nagai Y, et al. (1994) Molecular cloning and functional expression of a human thyrotropin-releasing hormone (TRH) receptor gene. Biochim Biophys Acta 1219: 251-259. (Pubitemid 24319681)
21. Shinohara T, Harada M, Ogi K, Maruyama M, Fujii R, et al. (2004) Identification of a G protein-coupled receptor specifically responsive to betaalanine. J Biol Chem 279: 23559-23564. (Pubitemid 38685669)
22. Arac D, Aust G, Calebiro D, Engel FB, Formstone C, et al. (2012) Dissecting signaling and functions of adhesion G protein-coupled receptors. Ann N Y Acad Sci 1276: 1-25.
23. Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopaminereceptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30: 228-235. (Pubitemid 46654239)
24. Takahashi H, Yamada M, Suhara T (2012) Functional significance of central D1 receptors in cognition: beyond working memory. J Cereb Blood Flow Metab 32: 1248-1258.
25. Yin H, Chu A, Li W, Wang B, Shelton F, et al. (2009) Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 284: 12328-12338.
26. Massart R, Guilloux JP, Mignon V, Sokoloff P, Diaz J (2009) Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents. Eur J Neurosci 30: 397-414.
27. Lobo MK, Cui Y, Ostlund SB, Balleine BW, Yang XW (2007) Genetic control of instrumental conditioning by striatopallidal neuron-specific S1P receptor Gpr6. Nat Neurosci 10: 1395-1397. (Pubitemid 350014677)
28. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, et al. (2008) Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135: 749-762.
29. Rich TC, Tse TE, Rohan JG, Schaack J, Karpen JW (2001) In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors. J Gen Physiol 118: 63-78.
30. Preskorn SH (2007) The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol. J Psychiatr Pract 13: 253-257. (Pubitemid 47222148)
31. Varchi G, Battaglia A, Samori C, Baldelli E, Danieli B, et al. (2005) Synthesis of deserpidine from reserpine. J Nat Prod 68: 1629-1631. (Pubitemid 41789570)
32. Meltzer HY (1992) Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 18: 515-542.
33. Erickson JD, Eiden LE, Hoffman BJ (1992) Expression cloning of a reserpinesensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A 89: 10993-10997.
34. Hikosaka O (2010) The habenula: from stress evasion to value-based decisionmaking. Nat Rev Neurosci 11: 503-513.
35. Bouwmeester H, Wolterink G, van Ree JM (2002) Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol 442: 239-249. (Pubitemid 34024371)
36. Lecourtier L, Defrancesco A, Moghaddam B (2008) Differential tonic influence of lateral habenula on prefrontal cortex and nucleus accumbens dopamine release. Eur J Neurosci 27: 1755-1762. (Pubitemid 351473573)
37. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, et al. (1997) Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385: 634-636.
38. Ananth J, Burgoyne KS, Gadasalli R, Aquino S (2001) How do the atypical antipsychotics work? J Psychiatry Neurosci 26: 385-394. (Pubitemid 34081562)
39. Royal SJ, Key B (1999) Development of P2 olfactory glomeruli in P2-internal ribosome entry site-tau-LacZ transgenic mice. J Neurosci 19: 9856-9864. (Pubitemid 30226659)
40. Clevenger AC, Salcedo E, Jones KR, Restrepo D (2008) BDNF promotermediated beta-galactosidase expression in the olfactory epithelium and bulb. Chem Senses 33: 531-539.
41. Walters E, Grillo M, Tarozzo G, Stein-Izsak C, Corbin J, et al. (1996) Proximal regions of the olfactory marker protein gene promoter direct olfactory neuronspecific expression in transgenic mice. J Neurosci Res 43: 146-160. (Pubitemid 26044229)
42. Treloar H, Walters E, Margolis F, Key B (1996) Olfactory glomeruli are innervated by more than one distinct subset of primary sensory olfactory neurons in mice. J Comp Neurol 367: 550-562. (Pubitemid 26121743)
43. Aggleton JP, Brown MW (1999) Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci 22: 425-444; discussion 444-489. (Pubitemid 29381683)
44. Matsumoto M, Hikosaka O (2007) Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447: 1111-1115. (Pubitemid 47014424)
45. Xiong G, Zhang L, Mojsilovic-Petrovic J, Arroyo E, Elkind J, et al. (2012) GABA and glutamate are not colocalized in mossy fiber terminals of developing rodent hippocampus. Brain Res 1474: 40-49.
46. Lei G, Anastasio NC, Fu Y, Neugebauer V, Johnson KM (2009) Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength. J Neurochem 109: 1017-1030.
47. Yui K, Ikemoto S, Ishiguro T, Goto K (2000) Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Ann N Y Acad Sci 914: 1-12.
48. Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends Pharmacol Sci 29: 493-498.
49. Roxo MR, Franceschini PR, Zubaran C, Kleber FD, Sander JW (2011) The limbic system conception and its historical evolution. ScientificWorldJournal 11: 2428-2441.
50. Ouagazzal AM, Jenck F, Moreau JL (2001) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity? Psychopharmacology (Berl) 156: 273-283. (Pubitemid 32702218)
51. Sharp FR, Tomitaka M, Bernaudin M, Tomitaka S (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24: 330-334. (Pubitemid 32455433)
52. Lindsley CW, Shipe WD, Wolkenberg SE, Theberge CR, Williams DL Jr, et al. (2006) Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem 6: 771-785.
53. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, et al. (2003) A G protein-coupled receptor responsive to bile acids. J Biol Chem 278: 9435-9440. (Pubitemid 36800434)